Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-κB inhibition

References

• Park EJ, Kim JY, Jeong MS, et al. Effect of topical application of quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside on atopic dermatitis in NC/Nga mice. J Dermatol Sci. 2015;77:166–172.
   PubMed Web of Science ®Google Scholar
• Gaspar K, Kukova G, Bunemann E, et al. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation. J Dermatol Sci. 2013;71:12–21.
   PubMed Web of Science ®Google Scholar
• Chen L, Martinez O, Overbergh L, et al. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol. 2004;138:375–387.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim MS, Jeong GS, et al. Xanthii fructus extract inhibits TNF-alpha/IFN-gamma-induced Th2-chemokines production via blockade of NF-kappaB, STAT1 and p38-MAPK activation in human epidermal keratinocytes. J Ethnopharmacol. 2015;171:85–93.
   PubMed Web of Science ®Google Scholar
• Kang BK, Kim MJ, Kim KB, et al. In vivo and in vitro inhibitory activity of an ethanolic extract of Sargassum fulvellum and its component grasshopper ketone on atopic dermatitis. Int Immunopharmacol. 2016;40:176–183.
   PubMed Web of Science ®Google Scholar
• Lee HG, Cho NC, Jeong AJ, et al. Immunomodulatory activities of the benzoxathiole derivative bot-4-one ameliorate pathogenic skin inflammation in mice. J Invest Dermatol. 2016;136:107–116.
   PubMed Web of Science ®Google Scholar
• Arumugam S, Sreedhar R, Thandavarayan RA, et al. Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium. Cytokine. 2015;74:305–312.
   PubMed Web of Science ®Google Scholar
• Osabe M, Tajika T, Tohkin M. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-kappaB activation. J Appl Toxicol. 2018;38:274–283.
   PubMed Web of Science ®Google Scholar
• Yoon NY, Jung M, Kim DH, et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. Arch Dermatol Res. 2015;307:569–581.
   PubMed Web of Science ®Google Scholar
• Choi EJ, Lee S, Kim HH, et al. Suppression of dust mite extract and 2,4-dinitrochlorobenzene-induced atopic dermatitis by the water extract of Lindera obtusiloba. J Ethnopharmacol. 2011;137:802–807.
   PubMed Web of Science ®Google Scholar
• Fang YP, Yang SH, Lee CH, et al. What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. Int J Pharm. 2016;497:277–286.
   PubMedGoogle Scholar
• Duan J, Sugawara T, Hirose M, et al. Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis. Exp Dermatol. 2012;21:448–452.
   PubMed Web of Science ®Google Scholar
• Cha BJ, Lee ED, Kim WB, et al. Enhanced skin permeation of a new capsaicin derivative (DA-5018) from a binary vehicle system composed of isopropyl myristate and ethoxydiglycol. Arch Pharm Res. 2001;24:224–228.
   PubMed Web of Science ®Google Scholar
• Koppes SA, Brans R, Ljubojevic Hadzavdic S, et al. Stratum corneum tape stripping: monitoring of inflammatory mediators in atopic dermatitis patients using topical therapy. Int Arch Allergy Immunol. 2016;170:187–193.
   PubMed Web of Science ®Google Scholar
• Shinoda K, Nakagawa K, Kosaka T, et al. Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Hum Immunol. 2010;71:763–770.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Umezawa K. Anti-inflammatory effects of novel AP-1 and NF-kappaB inhibitors in dextran-sulfate-sodium-induced colitis in rats. Int J Mol Med. 2016;37:1457–1464.
   PubMed Web of Science ®Google Scholar
• Iwata D, Kitaichi N, Miyazaki A, et al. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest Ophthalmol Vis Sci. 2010;51:2077–2084.
   PubMed Web of Science ®Google Scholar
• Hamasaka A, Yoshioka N, Abe R, et al. Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition. J Allergy Clin Immunol. 2010;126:400–403.
   PubMed Web of Science ®Google Scholar
• Jiang X, Lan Y, Wei B, et al. External application of NF-kappaB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice. Immunopharmacol Immunotoxicol. 2017;39:157–164.
   PubMed Web of Science ®Google Scholar
• Carretero M, Guerrero-Aspizua S, Illera N, et al. Differential features between chronic skin inflammatory diseases revealed in skin-humanized psoriasis and atopic dermatitis mouse models. J Invest Dermatol. 2016;136:136–145.
   PubMed Web of Science ®Google Scholar
• Baek JO, Lee JR, Roh JY, et al. Oral tolerance modulates the skin transcriptome in mice with induced atopic dermatitis. Allergy. 2018;73:962–966.
   PubMed Web of Science ®Google Scholar
• Mohammed D, Yang Q, Guy RH, et al. Comparison of gravimetric and spectroscopic approaches to quantify stratum corneum removed by tape-stripping. Eur J Pharm Biopharm. 2012;82:171–174.
   PubMed Web of Science ®Google Scholar
• Yeh CY, Jung CJ, Huang CN, et al. A legume product fermented by Saccharomyces cerevisiae modulates cutaneous atopic dermatitis-like inflammation in mice. BMC Complement Altern Med. 2014;14:194.
   PubMed Web of Science ®Google Scholar
• Cho SM, Kim ME, Kwon B, et al. Immunomodulatory effects induced by intramuscular administration of autologous total immunoglobulin G in patients with atopic dermatitis. Int Immunopharmacol. 2017;52:1–6.
   PubMed Web of Science ®Google Scholar
• Kim HI, Hong SH, Ku JM, et al. Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-kappaB activation in human mast cells and keratinocytes. BMC Complement Altern Med. 2017;17:186.
   PubMed Web of Science ®Google Scholar
• Bui TT, Piao CH, Song CH, et al. Bupleurum chinense extract ameliorates an OVA-induced murine allergic asthma through the reduction of the Th2 and Th17 cytokines production by inactivation of NFkappaB pathway. Biomed Pharmacother. 2017;91:1085–1095.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15:271–282.
   PubMed Web of Science ®Google Scholar
• Choi JK, Kim SH. Inhibitory effect of galangin on atopic dermatitis-like skin lesions. Food Chem Toxicol. 2014;68:135–141.
   PubMed Web of Science ®Google Scholar
• Jung MR, Lee TH, Bang MH, et al. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-beta-D-glucopyanosylspinasterol via blocking NF-kappaB and STAT1 signaling pathways in TNF-alpha and IFN-gamma-induced HaCaT keratinocytes. Biochem Biophys Res Commun. 2012;427:236–241.
   PubMed Web of Science ®Google Scholar